Treatment of severe psoriasis with anti-CD25 monoclonal antibodies

Arch Dermatol. 2000 May;136(5):675-6. doi: 10.1001/archderm.136.5.675.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Female
  • Flow Cytometry
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Psoriasis / blood
  • Psoriasis / drug therapy*
  • Receptors, Interleukin-2 / immunology*
  • Recombinant Fusion Proteins*
  • Severity of Illness Index
  • T-Lymphocyte Subsets / immunology

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Receptors, Interleukin-2
  • Recombinant Fusion Proteins
  • Basiliximab